Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06053268 · ClinicalTrials.gov registry record · NA

Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors

A NA study of Lymphoma and Leukemia, sponsored by St. Jude Children's Research Hospital.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06053268: Active NA study of Lymphoma and Leukemia, sponsored by St. Jude Children's Research Hospital.

NCT06053268 is a NA study of Lymphoma and Leukemia that is active but no longer recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 50 participants, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06053268, a NA study of Lymphoma and Leukemia, is active but no longer recruiting, sponsored by St. Jude Children's Research Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will explore feasibility and acceptability of using a daily mobile mindfulness app to cope with stress. In addition, feasibility of digital health data collection procedures including wrist-worn devices and ecological momentary assessments will be examined. PRIMARY OBJECTIVES * Determine the feasibility and acceptability of completing the 30-day mobile mindfulness program * Evaluate the feasibility of digital health data collection procedures to detect autonomic nervous system (ANS) activation associated with stress (e.g., electrodermal activity, pulse rate variability, skin temperature) via wearable devices and self-reported ecological momentary assessments (EMA) among adult survivors of childhood cancer in the SJLIFE cohort * Generate preliminary data to estimate the effect size and power needed for an extramurally funded randomized controlled trials (RCT) examining the impact of daily mindfulness mediation on biomarkers of ANS activation, coping, health behaviors, and cardiometabolic outcomes in a cohort of survivors of childhood cancer.

Primary Outcome

Mindfulness app adherence was defined as the proportion of participants who completed at least 4 meditation sessions on average during the 30-day intervention.

Interventions

  • DEVICE Headspace

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-05-23
Est. Completion 2026-09-27
Phase NA

What the registry record for NCT06053268 still lists

NCT06053268 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (90% lower).

The record links to 3 conditions, with Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which Headspace is the first listed.

NCT06053268 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT06053268 about?

NCT06053268 is a clinical study titled "Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors". This study will explore feasibility and acceptability of using a daily mobile mindfulness app to cope with stress. In addition, feasibility of digital health data collection procedures including wrist-worn devices and ecological momentary assessments will be examined. PRIMARY OBJECTIVES * Determin...

What is the current status of trial NCT06053268?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-05-23. Estimated completion is 2026-09-27.

What conditions does trial NCT06053268 study?

This clinical trial studies the following conditions: Lymphoma, Leukemia, Childhood Cancer.

What interventions are being tested in trial NCT06053268?

The interventions under investigation include: Headspace (DEVICE).

Who is sponsoring clinical trial NCT06053268?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06053268 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06053268's enrollment target sits among peer trials

50 148th of 299 higher than 145 of 299 other Lymphoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06053268, the US trial registry maintained by the National Library of Medicine. NCT06053268 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.